[Skip to content]

Private Healthcare UK
Search our Site

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.


HPV tests should be incorporated into cancer treatment programmes

Cancer research logo

Human papillomavirus (HPV) testing may be the first phrase in a new comprehensive cervical cancer treatment programme.

The virus affects around eight in ten people in the UK at some point in their lives and is a major contributor to a women's risk of cervical tumours.

A new study funded by Cancer Research UK has found that HPV testing should be carried out to ascertain if a woman is at risk of cancer.

Those patients who display severe surgical changes – known as CIN3 – could then be sent for further smear tests. Scientists believe this to be the most optimal method of balancing unnecessary procedures with helping to identify those most at risk.

Officials have wanted to increase the amount of HPV tests conducted in the UK for some time and now this study sheds light on the best way to implement these changes.

Sara Hoim, director of information at Cancer Research UK said: "The findings help answer some of the questions that would need to be considered should the UK refine its highly effective cervical screening programme."

© Adfero Ltd


Cancer treatment news : 7 March 2012